این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
جمعه 1 اسفند 1404
International Journal of Hematology-Oncology and Stem Cell Research
، جلد ۳، شماره ۳، صفحات ۴-۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
A Preliminary Report on the Feasibility of Outpatient Autologous Stem Cell Transplantation in Iran
چکیده انگلیسی مقاله
Introduction: Autologous stem cells have greatly influenced the treatment of a variety of malignancies including Hodgkin/non-Hodgkins lymphoma and acute leukemias. This is a preliminary study comparing the time of engraftment, mortality rate and cost of treatment in outpatient versus inpatient autologous stem cell transplantation (SCT) in Iran. Patients and Methods: 11 outpatients (6 Hodgkin Lymphoma (HL), 3 Non-Hodgkin Lymphoma (NHL) and 2 Acute Myeloid Leukemia (AML)) were compared with 32 inpatients (15 HL, 8 NHL and 9 AML) from May, 2008 to December, 2008. All patients were in complete remission and without significant organ failure. They received conditioning regimen (CEAM for NHL and HL, Busulfan and Etoposide for AML) and stem cell infusion in hospital. The day after SCT, the outpatient group was discharged and followed up by an outpatient SCT team to be re-hospitalized, if indicated. Results : For outpatients and inpatients, the median period to WBC engraftment was 11 and 12 days (p-value=0.03), the timeframe to PLT engraftment was 15 and 25 days (p-value=0.20) and the number of transfused single-donor PLT was 3 and 4.5 units (p-value=0.21). The duration of neutropenic fever was 6 and 9 days (p-value=0.001), the duration of hospitalization after SCT was 0 and 16 (p-value< 0.001), respectively. All outpatients are alive but three inpatients died between days +35 and +100 following SCT due to transplantation complications. The cost of the drugs used for treatment of neutropenic fever was 6 times higher in the inpatient group. Conclusion: The outpatient autologous SCT in malignant hematological disorders is feasible and comparable to inpatient protocols in Iran.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
اردشیر قوام زاده | ardeshir ghavamzadeh
hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
ابوالقاسم الهیاری | abolghasem allahyari
hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
کامران علی مقدم | kamran alimoghaddam
hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
m esfandbod | m esfandbod
hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
m ملک پور | m malekpour
hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
اکرم کریمی | akram karimi
hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
آرپی مانوکیان | arpi manokian
hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
m اسدیان | m asadian
hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
فرناز خاتمی | farnaz khatami
hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
نشانی اینترنتی
http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/216
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Articles
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات